The 20 Best Cone-Rod Dystrophy Doctors near New York, NY

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Doyne Honeycomb Retinal Dystrophy, and Cone Dystrophy.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Dr. Fisher is a clinical ophthalmologist specializing in vitreoretinal diseases. Dr. Fisher’s career is noteworthy in the areas of patient care, teaching, and research. He is the author of several textbooks in the field of vitreoretinal diseases and ultrasonography.AuthorDr. Fisher has published more than 50 scientific articles and numerous scientific exhibits and posters. He was a course director for the American Academy of Ophthalmology for over 22 years and a review editor for many prestigious ophthalmic journals. He has received numerous awards for national and international professorships and lectureships. He has also been awarded the coveted Senior Award from the American Academy of Ophthalmology.LecturesDr. Fisher has lectured throughout the United States and abroad in the areas of ultrasonography and vitreoretinal surgery, developing new techniques and instruments in his field as well as pioneering developments in ocular endoscopy. He was selected by departmental chairmen and section chiefs at major ophthalmology centers nationwide as one of the 400 best retina doctors in America.Developed InstrumentsDr. Fisher has developed numerous intraocular surgical instruments which have advanced the field of vitreoretinal surgery. These instruments include electromagnets as well as endoscopic techniques for situations where microscopic visualization is limited or impossible. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Adult-Onset Vitelliform Macular Dystrophy (AVMD), Age-Related Macular Degeneration (ARMD), Retinal Detachment, and Vitrectomy.

Richard Rosen is an Ophthalmologist in New York, New York. Dr. Rosen is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Retinitis Pigmentosa, X-Linked Retinitis Pigmentosa (XLRP), Endophthalmitis, and Cone Dystrophy.

Susan Fromer is an Ophthalmologist in New York, New York. Dr. Fromer is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Glaucoma, Kallikrein Hypertension, Allergic Conjunctivitis, and Meibomianitis.

Talia Kaden is a General Surgeon and an Ophthalmologist in New York, New York. Dr. Kaden is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.

David C. Ritterband MD, FACS is a Professor of Ophthalmology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Prior to joining Manhattan Eye, Ear and Throat Hospital (MEETH)/Northwell Eye Institute, he was a Professor of Ophthalmology at the Icahn School of Medicine at Mt Sinai and System Director of the Refractive Surgery Service for the Mount Sinai Health System. At MEETH he has assumed leadership of the Refractive Surgery division and the Laser Vision Correction Center and sees patients at the Manhattan Eye, Ear and Throat Hospital on 64th Street. Dr. Ritterband is a graduate of Duke University and received his medical degree at New York Medical College where he was elected to Alpha Omega Alpha, the national medical honor society. He completed his Ophthalmology Residency at New York Medical College where he was elected Chief Resident. He completed his Corneal and External disease and Refractive Surgery Fellowship at the University of Pittsburgh School of Medicine Eye and Ear Institute. He is a fellow of the American Academy of Ophthalmology and the American College of Surgeons. He is a past president of the Ocular Microbiology and Immunology Group and a long time Medical Board member of the Eye Bank for Sight Restoration in New York City, the world's first Eye Bank. In addition to maintaining a busy tertiary-care referral practice in New York City, Dr. Ritterband is a nationally recognized physician, scientist, and surgeon. He has published over 250 medical and scientific papers, book chapters, monographs, and research abstracts. He has lectured widely in the United States on cornea, cataract, and refractive surgery topics. His clinical and research interests include cornea transplantation, cataract surgery, ocular drug development, laser refractive surgery, and ocular infections. A committed teacher and mentor, he has trained over 50 clinical cornea fellows first at the highly regarded AUPO certified corneal fellowship program at the New York Eye and Ear Infirmary and continuing with the current AUPO corneal fellowship program at Manhattan Eye, Ear and Throat Hospital. Dr. Ritterband has received numerous awards including an Honor Award from the American Academy of Ophthalmology and has been named multiple times to New York Magazine's Best Doctors, Castle Connolly's Top Doctors, and the NY Times Magazine's Super Doctors. In addition, while at the New York Eye and Ear Infirmary he received 6 Resident Outstanding Teaching and Dedicated Service Awards. Dr. Ritterband is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Cataract, Endophthalmitis, Interstitial Keratitis, Corneal Transplant, and Trabeculectomy.

Dr. Barile is Professor of Ophthalmology, Zucker School of Medicine at Hofstra /Northwell, and Director of Ophthalmology Research, Manhattan Eye, Ear and Throat Hospital. He previously served as the John Wilson Espy MD Professor of Clinical Ophthalmology and Glaubinger Scholar in Retina Research at Columbia University. Dr. Barile has lectured widely, has authored or coauthored more than eighty publications, and is a member of numerous professional societies and organizations including the Macula and Retina Societies. Among several honors, Dr. Barile received an Achievement Award from the American Academy of Ophthalmology and a Senior Honor Award from the American Society of Retina Specialists. Dr. Barile is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Retinal Vein Occlusion, and Vitrectomy.

David Rubaltelli is an Ophthalmologist in Brooklyn, New York. Dr. Rubaltelli is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Diabetic Retinopathy, Kallikrein Hypertension, Congenital Toxoplasmosis, and Late-Onset Retinal Degeneration.

Nancy Coles is an Ophthalmologist in New York, New York. Dr. Coles is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Dry Eye Syndrome, Cataract, Glaucoma, and Choroid Plexus Carcinoma.

Louis Angioletti is an Ophthalmologist in New York, New York. Dr. Angioletti is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Geographic Atrophy, and Retinal Vein Occlusion.

My practice focuses on cataract and refractive surgery using advanced technology, multifocal intraocular lenses and laser treatment to improve people's vision and make them less dependent on glasses. Each patient is unique and different approaches are applied depending on the individual's lifestyle needs. I deliver world class care and surgery to the patient in order to help them achieve their goals. Dr. Ellant is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Interstitial Keratitis, Blepharitis, Eyelid Bump, and Cataract.

Brian Campolattaro is an Ophthalmologist in New York, New York. Dr. Campolattaro is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Strabismus, Esotropia, Brown Syndrome, and Coloboma of Optic Papilla.

K. Bailey Freund, MD specializes in diagnosis, treatment and care of patients with all retinal disorders including macular degeneration, diabetic retinopathy, and retinal vascular and inflammatory diseases and is an expert in difficult-to-diagnose and rare conditions. He has been at the forefront of pivotal national clinical trials as a principal investigator for treatments for retinal diseases, providing his patients access to the latest solutions and remedies utilizing the most state of the art diagnostic equipment.Dr. Freund is internationally recognized in his field and is a member of the Retina Society, Macula Society, and the American Society of Retina Specialists. He is on the Editorial Board of the journal Retina and is an Associate Editor for Retinal Cases & Brief Reports. He has authored over 250 peer-reviewed scientific manuscripts and has written numerous book chapters. He has received numerous awards including the prestigious Young Investigator Award from the Macula Society.He is a graduate of Williams College and the New York University School of Medicine and completed his residency training in general ophthalmology and fellowship in medical and surgical retina at the Manhattan Eye, Ear, and Throat Hospital. Dr. Freund was born and raised in Manhattan and continues to reside here with his wife and his two children. Dr. Freund enjoys playing the guitar and is a prominent collector of vintage magic apparatus. Dr. Freund is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Choroid Plexus Carcinoma.

Michael Engelbert, MD, PhD, a vitreoretinal surgeon and macular disease specialist, provides both medical care for age-related macular degeneration and diabetic eye disease as well as surgical management of macular disease and retinal detachment repair, including complex detachments from diabetes and after trauma or failed primary repair. He also specializes in secondary intraocular lens implantation after complicated cataract surgery. He is an internationally renowned expert on vitreous anatomy and vitreoretinal interface disorders, topics on which he lectures at home and abroad.Dr. Engelbert received his medical degree Magna Cum Laude from Ludwig-Maximilians-University in Munich, Germany, after which he dedicated himself several years to basic research in the study of endophthalmitis, a vision-threatening infection, that can occur after eye surgery. He earned a Ph.D. for this work and is considered a leader in this field.Before joining the residency program at Columbia University, Dr. Engelbert served his internship at Griffin Hospital, a Yale-affiliated center in Connecticut, where he was granted the Vincent D. DeLuca award for the best medical intern.Afterward, he was resident and chief resident in the Department of Ophthalmology of Columbia University’s College of Physicians and Surgeons at the Edward S. Harkness Eye Institute on the Columbia Presbyterian Medical Center Campus. Following his residency training, Dr. Engelbert was awarded a medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University.Dr. Engelbert is a member of The American Society of Retina Specialists (ASRS), The European Society of Vitreoretinal Specialists (EVRS), the Association for Research in Vision and Ophthalmology (ARVO), and The American Academy of Ophthalmology (AAO) and the prestigious Club Jules Gonin. He has published numerous papers on retinal disease, received several awards and has been granted permanent resident status in the United States in the category “outstanding scientist”. He serves as a reviewer for the premier journals in the field, including the Archives of Ophthalmology, Ophthalmology, Investigative Ophthalmology and Visual Sciences, Retina, Eye, and Graefe’s Archives of Clinical and Experimental Ophthalmology.He is a Research Assistant Professor at New York University and Clinical Instructor at NYU , where he is actively involved in instructing residents and fellows in the art of medical retina and retinal surgery, and provides care for an underserved population with often advanced disease requiring complex surgical intervention. Dr. Engelbert is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.

Irene A. Barbazetto, M.D. is a vitreoretinal surgeon and macular disease specialist board certified in the United States and Europe. She is an internationally recognized expert in the treatment of macular degeneration, retinal vascular disease, retinal vein occlusion, hereditary retinal disease, and diabetes.The author of more than 40 peer-reviewed articles and book chapters, she serves on the Editorial Board of the prestigious journal Graefe’s Archive of Clinical and Experimental Ophthalmology. Dr. Barbazetto is the recipient of the 2009 Achievement Award from the American Academy of Ophthalmology. Her patients voted her as one of the best retina doctors, America’s “Most Compassionate Physicians,” and she received the “Patient’s Choice Award” in 2010. A graduate of Hamburg University, Germany, Dr. Barbazetto’s doctoral thesis investigated a newly developed vision-screening test (H-Test) for pre-school children and was awarded cum laude. She completed her ophthalmology residency in Lübeck, Germany, where she participated in the development of photodynamic therapy for the treatment of macular degeneration.In 2000, she came to New York for a research fellowship with Dr. Stanley Chang at Columbia University, focusing on the role of oxygen in the development of cataract after vitreoretinal surgery. She completed an internship in general surgery at the Lenox Hill Hospital in Manhattan and an ophthalmology residency at Columbia University. Dr. Barbazetto is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Adult-Onset Vitelliform Macular Dystrophy (AVMD).

Dr. Klancnik utilizes all forms of ophthalmic imaging including fluorescein angiography, indocyanine green angiography, as well as noninvasive forms of imaging such as spectral domain optical coherence tomography, autofluorescence photography, and ultrasonography.Dr. Klancnik is a magna cum laude graduate of Yale University. He earned his medical degree from Jefferson Medical College of Thomas Jefferson University and was elected to the Alpha Omega Alpha and Hobart Amory Hare honor medical societies. He completed his internship at the Lankenau Hospital and his ophthalmology residency at Wills Eye Hospital. He completed his medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University. He is an Assistant Professor of Clinical Ophthalmology at New York University School of Medicine.Dr. Klancnik is a member of numerous medical organizations including the American Academy of Ophthalmology, American Society of Retinal Specialists, and Association for Research in Vision and Ophthalmology. He is an author of numerous peer-reviewed journal articles and book chapters and has presented at scientific meetings nationally and internationally. He is active in numerous clinical trials as principle or sub-investigator and serves as a reviewer for several ophthalmology journals. Dr. Klancnik is rated as an Advanced provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion.

Golnaz Moazami is an Ophthalmologist in New York, New York. Dr. Moazami is rated as an Experienced provider by MediFind in the treatment of Cone-Rod Dystrophy. Her top areas of expertise are Optic Atrophy Type 1, Optic Nerve Atrophy, Ocular Hypertension (OHT), and Fourth Cranial Nerve Palsy.

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Sorsby Fundus Dystrophy, Leber Congenital Amaurosis, and Usher Syndrome.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as a Distinguished provider by MediFind in the treatment of Cone-Rod Dystrophy. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.